Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia-Reference-Cited by-同舟云学术

Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia

Published:2015-04-27 Issue:4 Volume:10 Page:e0117125
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gleason Rudolph L.,Caulk Alexander W.,Seifu Daniel,Parker Ivana,Vidakovic Brani,Getenet Helena,Assefa Getachew,Amogne Wondwossen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference87 articles.

1. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study;A Carr;Lancet,1999

2. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men;M Mary-Krause;AIDS,2003

3. Combination antiretroviral therapy and the risk of myocardial infarction;N Friis-Moller;New England Journal of Medicine,2003

4. Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study;P Maggi;AIDS,2004

5. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy;K Sevastianova;Antivir Ther,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of impact of HIV status on carotid intima media thickness in a cohort of stroke patients in South Africa;Journal of the Neurological Sciences;2024-10

2. The association of menopause with cardiometabolic disease risk factors in women living with and without HIV in sub-Saharan Africa: Results from the AWI-Gen 1 study;Maturitas;2024-09

3. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis;BMC Infectious Diseases;2024-02-02

4. Endothelial dysfunction, a predictor of cardiovascular disease in HIV patients on antiretroviral therapy: A systematic review and meta-analysis;Thrombosis Research;2024-02

5. Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021;HIV/AIDS - Research and Palliative Care;2024-02